Previous 10 | Next 10 |
Novavax Reports Second Quarter 2023 Financial Results and Operational Highlights PR Newswire Second quarter total revenue of $424 million and net income of $58 million Executed new strategic partnering agreement with SK bioscience, including an equity investm...
2023-08-08 06:40:24 ET Novavax press release ( NASDAQ: NVAX ): Q2 GAAP EPS of $0.58 beats by $1.74 . Revenue of $424.43M (+128.3% Y/Y) beats by $165.44M . The company had $517.9 million in cash and cash equivalents and restricted cash. For further details...
2023-08-07 13:14:48 ET More on Novavax Novavax Faces Uphill Battle In Competitive Vaccine Market: Analysis And Recommendation Novavax: Sell The Covid Rips Novavax, Inc. ( NVAX ) Presents at BofA Securities 2023 Health Care Conference Novavax adds 28% afte...
2023-08-07 11:20:35 ET Major earnings expected before the bell on Tuesday include: Duke Energy ( DUK ) Barrick Gold ( GOLD ) Medical Properties Trust ( MPW ) Organon ( OGN ) United Parcel Service ( UPS ) For further details see: Notable ea...
2023-08-06 08:01:00 ET The second week of August promises to be an eventful one for investors as a slew of major companies is set to report quarterly results. Among the headliners, Disney ( NYSE: DIS ) is prehaps the most well-known company due to report. The schedule also incl...
2023-08-02 20:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Novavax to Host Conference Call to Discuss Second Quarter 2023 Financial Results and Operational Highlights on August 8, 2023 PR Newswire GAITHERSBURG, Md. , Aug. 1, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based ...
2023-07-31 18:24:41 ET News of a fresh COVID-19 surge sent numerous stockholders into the shares of vaccine maker Novavax (NASDAQ: NVAX) on the first trading day of the week. As a result, Novavax's shares popped more than 13% higher in anticipation that the company's wares would be ...
2023-07-20 08:15:00 ET Shares of Novavax (NASDAQ: NVAX) have been jumping in the past month, and they are up around 25% since April. There's an influx of money coming its way due to unused COVID shots in Canada, which means the company's cash situation will improve. But before you r...
2023-07-13 14:39:00 ET Shares of Novavax (NASDAQ: NVAX) lost 28% of their value in the first six months of the year, according to data from S&P Global Market Intelligence , extending a downtrend that began in early 2022. The pharmaceutical company's COVID-19 vaccine not only...
News, Short Squeeze, Breakout and More Instantly...
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine Canada NewsWire Novavax's COVID-19 vaccine would be the only protein-based option available in Canada , if authorized Novavax's filing is aligned with NACI, ...